2006
DOI: 10.1016/j.jconrel.2006.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Molecular design of biodegradable polymeric micelles for temperature-responsive drug release

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
210
0
4

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 350 publications
(217 citation statements)
references
References 33 publications
3
210
0
4
Order By: Relevance
“…Drug release from a thermosensitive polymer micelle upon temperature increase. Reproduced from [37] with permission. Illustration of the "tandem" gelation process.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Drug release from a thermosensitive polymer micelle upon temperature increase. Reproduced from [37] with permission. Illustration of the "tandem" gelation process.…”
Section: Discussionmentioning
confidence: 99%
“…Recent developments on pNiPAAm-based hydrogels include their use for drug delivery [12,13,37,38], cell encapsulation and delivery [39,40] and cell culture surfaces [41]. Poly(Nisopropylacrylamide) is non-biodegradable and exhibits a sharp phase transition, with an LCST at about 32°C in pure water [37,42].…”
Section: N-isopropylacrylamide-based Systemsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, when the temperature was kept higher than 40°C, the size remained the same, indicating an LCST of~38°C. The average thickness of the polymer shell on the surface of Cu 7 (Fig. 1f).…”
Section: Synthesis and Characterization Of Nanocompositesmentioning
confidence: 99%
“…Up to now, smart drug delivery platforms triggered by stimuli such as pH [3][4][5][6], temperature [7], magnetic field [8][9][10] and glutathione existing in cytoplasmic matrix [11,12] have been designed, which overcome the current shortcoming of DDSs that release drugs following a predetermined rate after administration, irrespective of the patients' needs [13]. These smart DDSs offer the possibility to remotely and noninvasively control the drug release, which would substantially improve treatment efficacy and reduce side effects [14].…”
Section: Introductionmentioning
confidence: 99%